Combo of targeted drugs may prove more effective in leukemia fightOctober 21st, 2008 - 2:35 pm ICT by ANI
Washington, Oct 21 (ANI): A recent discovery by scientists suggests that the most effective treatment for leukemia may rely on a combination of targeted drugs, rather than a single miracle drug.
An anti-leukemia drug called imatinib is currently the most popular therapy for chronic myeloid leukemia (CML).
CML is associated with the abnormal fusion of a portion of chromosome 21 with a cell growth-promoting enzyme called ABL, which makes the enzyme perpetually active.
Imatinib slows down the spread of cancer by blocking the enzyme’’s activity.
However, the drug doesn”t work in everyone and resistance often develops, most likely because the drug only targets mature cells, leaving self-renewing cancer stem cells behind.
Now, Xiaoyan Jiang and a team of researchers from the British Columbia Cancer Agency in Vancouver and other institutions may have discovered what protects the stem cells from imatinib.
The team found that a protein called AHI-1, which has been found in leukemia cells in the past, is highly expressed in CML stem cells.
When the researchers blocked AHI-1 in cancer cells from imatinib-resistant CML patients, they restored the ability of the drug to kill the cells.
Jiang says the next step is finding a drug that blocks AHI-1, which could potentially be given in combination with imatinib in the future.
The study will appear online on October 20 in the Journal of Experimental Medicine. (ANI)
- 'Chewing betel leaf may help fight cancer' - Sep 18, 2012
- New study shows evidence of stem cells' pivotal role in cancer - Dec 22, 2010
- Now, a one-two drug punch approach to KO a lethal cancer - Jun 08, 2009
- SC again asks Novartis to cut cancer drug price - Sep 12, 2012
- Bioengineered protein may help fight leukemia - Feb 19, 2011
- Gene mutation behind onset of acute myeloid leukaemia identified - Mar 28, 2011
- Long-sought-after anti-cancer agent synthesized - Feb 01, 2011
- Overabundance of protein promotes growth of breast cancer stem cells - Feb 16, 2011
- Key cause of chronic leukemia progression identified - Mar 05, 2010
- Zebrafish offers skin cancer clues - Apr 06, 2011
- Mechanism that turns healthy cells into prostate cancer cells discovered - Dec 03, 2010
- Novel approach for leukaemia treatment discovered - Mar 04, 2010
- New therapeutic target for leukaemia identified - Jan 28, 2010
- Key pathway implicated in progression of childhood cancer found - Sep 19, 2010
- Novel way to kill treatment-resistant breast cancer stem cells - Jan 05, 2010
Tags: abl, british columbia cancer agency, cancer cells, chromosome 21, chronic myeloid leukemia, cml patients, discovery, imatinib, institutions, journal of experimental medicine, leukemia, leukemia cells, leukemia drug, mature cells, miracle drug, protein, resistance, scientists, stem cells, vancouver